MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
NCT03732833
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
425
Enrollment
INDUSTRY
Sponsor class
Conditions
Lateral Canthal Lines
Glabellar Lines
Interventions
DRUG:
MT10109L
DRUG:
Placebo
Sponsor
Medy-Tox